img

Global Model Organism Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends

Publisher : MRA | Format : PDF

Global Model Organism Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

A model organism is a species that has been widely studied, usually because it is easy to maintain and breed in a laboratory setting and has particular experimental advantages. Model organisms are non-human species that are used in the laboratory to help scientists understand biological processes.
Due to the COVID-19 pandemic, the global Model Organism market size was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the forecast period 2023-2033. Fully considering the economic change by this health crisis, Prokaryote accounting for % of the Model Organism global market in 2023, is projected to value US$ million by 2033, growing at a revised % CAGR from 2023 to 2033. While Drug Discovery segment is altered to an % CAGR throughout this forecast period.
The global key companies of Model Organism include Shanghai Model Organisms Center, Inc., Gem Pharmatech Co., Ltd., Charles River Laboratories, Envigo, Taconic Biosciences, Jackson Laboratory, Shanghai SLAC, Joinn Laboratories and Crown Biosciences, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
The United States Model Organism market size was US$ million in 2023, while China size was US$ million. The proportion of the United States was % in 2023, while China percentage was %, and it is predicted that China share will reach % in 2033, trailing a CAGR of % through the analysis period. As for the Europe Model Organism landscape, Germany is projected to reach US$ million by 2033. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Model Organism market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Model Organism market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Model Organism market. Readers of the report can become informed about current and future trends of the global Model Organism market and how they will impact market growth during the forecast period.



By Company


Shanghai Model Organisms Center, Inc.
Gem Pharmatech Co., Ltd.
Charles River Laboratories
Envigo
Taconic Biosciences
Jackson Laboratory
Shanghai SLAC
Joinn Laboratories
Crown Biosciences
Pharmalegacy
Syngene International
Janvier Labs
GenOway
Psychogenics
Horizon Discovery Group
Vitalstar Biotechnology
Segment by Type
Prokaryote
Eukaryote

Segment by Application


Drug Discovery
Basic Research
Toxicity Test
Parasitological Study
Hereditary Disease Study
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of Model Organism in global and regional level.
Chapter 3Detailed analysis of Model Organism companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Model Organism revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Model Organism Market Size Growth Rate by Type: 2018 VS 2023 VS 2033
1.2.2 Prokaryote
1.2.3 Eukaryote
1.3 Market by Application
1.3.1 Global Model Organism Market Growth Rate by Application: 2018 VS 2023 VS 2033
1.3.2 Drug Discovery
1.3.3 Basic Research
1.3.4 Toxicity Test
1.3.5 Parasitological Study
1.3.6 Hereditary Disease Study
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global Model Organism Market Size (2018-2033)
2.2 Model Organism Market Size across Key Geographies Worldwide: 2018 VS 2023 VS 2033
2.3 Global Model Organism Market Size by Region (2018-2023)
2.4 Global Model Organism Market Size Forecast by Region (2024-2033)
2.5 Global Top 10 Model Organism Countries Ranking by Market Size
3 Model Organism Competitive by Company
3.1 Global Model Organism Revenue by Players
3.1.1 Global Model Organism Revenue by Players (2018-2023)
3.1.2 Global Model Organism Market Share by Players (2018-2023)
3.2 Global Model Organism Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Model Organism Revenue
3.4 Global Model Organism Market Concentration Ratio
3.4.1 Global Model Organism Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Model Organism Revenue in 2023
3.5 Global Key Players of Model Organism Head office and Area Served
3.6 Global Key Players of Model Organism, Product and Application
3.7 Global Key Players of Model Organism, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Model Organism Breakdown Data by Type
4.1 Global Model Organism Historic Revenue by Type (2018-2023)
4.2 Global Model Organism Forecasted Revenue by Type (2024-2033)
5 Global Model Organism Breakdown Data by Application
5.1 Global Model Organism Historic Market Size by Application (2018-2023)
5.2 Global Model Organism Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Model Organism Revenue by Company (2021-2023)
6.2 North America Model Organism Revenue by Type (2018-2033)
6.3 North America Model Organism Revenue by Application (2018-2033)
6.4 North America Model Organism Revenue by Country (2018-2033)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Model Organism Revenue by Company (2021-2023)
7.2 Europe Model Organism Revenue by Type (2018-2033)
7.3 Europe Model Organism Revenue by Application (2018-2033)
7.4 Europe Model Organism Revenue by Country (2018-2033)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Model Organism Revenue by Company (2021-2023)
8.2 Asia Pacific Model Organism Revenue by Type (2018-2033)
8.3 Asia Pacific Model Organism Revenue by Application (2018-2033)
8.4 Asia Pacific Model Organism Revenue by Region (2018-2033)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Model Organism Revenue by Company (2021-2023)
9.2 Latin America Model Organism Revenue by Type (2018-2033)
9.3 Latin America Model Organism Revenue by Application (2018-2033)
9.4 Latin America Model Organism Revenue by Country (2018-2033)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Model Organism Revenue by Company (2021-2023)
10.2 Middle East and Africa Model Organism Revenue by Type (2018-2033)
10.3 Middle East and Africa Model Organism Revenue by Application (2018-2033)
10.4 Middle East and Africa Model Organism Revenue by Country (2018-2033)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Shanghai Model Organisms Center, Inc.
11.1.1 Shanghai Model Organisms Center, Inc. Company Details
11.1.2 Shanghai Model Organisms Center, Inc. Business Overview
11.1.3 Shanghai Model Organisms Center, Inc. Model Organism Products and Services
11.1.4 Shanghai Model Organisms Center, Inc. Model Organism Revenue in Model Organism Business (2018-2023)
11.1.5 Shanghai Model Organisms Center, Inc. Model Organism SWOT Analysis
11.1.6 Shanghai Model Organisms Center, Inc. Recent Development
11.2 Gem Pharmatech Co., Ltd.
11.2.1 Gem Pharmatech Co., Ltd. Company Details
11.2.2 Gem Pharmatech Co., Ltd. Business Overview
11.2.3 Gem Pharmatech Co., Ltd. Model Organism Products and Services
11.2.4 Gem Pharmatech Co., Ltd. Model Organism Revenue in Model Organism Business (2018-2023)
11.2.5 Gem Pharmatech Co., Ltd. Model Organism SWOT Analysis
11.2.6 Gem Pharmatech Co., Ltd. Recent Development
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Details
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories Model Organism Products and Services
11.3.4 Charles River Laboratories Model Organism Revenue in Model Organism Business (2018-2023)
11.3.5 Charles River Laboratories Model Organism SWOT Analysis
11.3.6 Charles River Laboratories Recent Development
11.4 Envigo
11.4.1 Envigo Company Details
11.4.2 Envigo Business Overview
11.4.3 Envigo Model Organism Products and Services
11.4.4 Envigo Model Organism Revenue in Model Organism Business (2018-2023)
11.4.5 Envigo Model Organism SWOT Analysis
11.4.6 Envigo Recent Development
11.5 Taconic Biosciences
11.5.1 Taconic Biosciences Company Details
11.5.2 Taconic Biosciences Business Overview
11.5.3 Taconic Biosciences Model Organism Products and Services
11.5.4 Taconic Biosciences Model Organism Revenue in Model Organism Business (2018-2023)
11.5.5 Taconic Biosciences Model Organism SWOT Analysis
11.5.6 Taconic Biosciences Recent Development
11.6 Jackson Laboratory
11.6.1 Jackson Laboratory Company Details
11.6.2 Jackson Laboratory Business Overview
11.6.3 Jackson Laboratory Model Organism Products and Services
11.6.4 Jackson Laboratory Model Organism Revenue in Model Organism Business (2018-2023)
11.6.5 Jackson Laboratory Model Organism SWOT Analysis
11.6.6 Jackson Laboratory Recent Development
11.7 Shanghai SLAC
11.7.1 Shanghai SLAC Company Details
11.7.2 Shanghai SLAC Business Overview
11.7.3 Shanghai SLAC Model Organism Products and Services
11.7.4 Shanghai SLAC Model Organism Revenue in Model Organism Business (2018-2023)
11.7.5 Shanghai SLAC Model Organism SWOT Analysis
11.7.6 Shanghai SLAC Recent Development
11.8 Joinn Laboratories
11.8.1 Joinn Laboratories Company Details
11.8.2 Joinn Laboratories Business Overview
11.8.3 Joinn Laboratories Model Organism Products and Services
11.8.4 Joinn Laboratories Model Organism Revenue in Model Organism Business (2018-2023)
11.8.5 Joinn Laboratories Model Organism SWOT Analysis
11.8.6 Joinn Laboratories Recent Development
11.9 Crown Biosciences
11.9.1 Crown Biosciences Company Details
11.9.2 Crown Biosciences Business Overview
11.9.3 Crown Biosciences Model Organism Products and Services
11.9.4 Crown Biosciences Model Organism Revenue in Model Organism Business (2018-2023)
11.9.5 Crown Biosciences Model Organism SWOT Analysis
11.9.6 Crown Biosciences Recent Development
11.10 Pharmalegacy
11.10.1 Pharmalegacy Company Details
11.10.2 Pharmalegacy Business Overview
11.10.3 Pharmalegacy Model Organism Products and Services
11.10.4 Pharmalegacy Model Organism Revenue in Model Organism Business (2018-2023)
11.10.5 Pharmalegacy Model Organism SWOT Analysis
11.10.6 Pharmalegacy Recent Development
11.11 Syngene International
11.11.1 Syngene International Company Details
11.11.2 Syngene International Business Overview
11.11.3 Syngene International Model Organism Products and Services
11.11.4 Syngene International Model Organism Revenue in Model Organism Business (2018-2023)
11.11.5 Syngene International Recent Development
11.12 Janvier Labs
11.12.1 Janvier Labs Company Details
11.12.2 Janvier Labs Business Overview
11.12.3 Janvier Labs Model Organism Products and Services
11.12.4 Janvier Labs Model Organism Revenue in Model Organism Business (2018-2023)
11.12.5 Janvier Labs Recent Development
11.13 GenOway
11.13.1 GenOway Company Details
11.13.2 GenOway Business Overview
11.13.3 GenOway Model Organism Products and Services
11.13.4 GenOway Model Organism Revenue in Model Organism Business (2018-2023)
11.13.5 GenOway Recent Development
11.14 Psychogenics
11.14.1 Psychogenics Company Details
11.14.2 Psychogenics Business Overview
11.14.3 Psychogenics Model Organism Products and Services
11.14.4 Psychogenics Model Organism Revenue in Model Organism Business (2018-2023)
11.14.5 Psychogenics Recent Development
11.15 Horizon Discovery Group
11.15.1 Horizon Discovery Group Company Details
11.15.2 Horizon Discovery Group Business Overview
11.15.3 Horizon Discovery Group Model Organism Products and Services
11.15.4 Horizon Discovery Group Model Organism Revenue in Model Organism Business (2018-2023)
11.15.5 Horizon Discovery Group Recent Development
11.16 Vitalstar Biotechnology
11.16.1 Vitalstar Biotechnology Company Details
11.16.2 Vitalstar Biotechnology Business Overview
11.16.3 Vitalstar Biotechnology Model Organism Products and Services
11.16.4 Vitalstar Biotechnology Model Organism Revenue in Model Organism Business (2018-2023)
11.16.5 Vitalstar Biotechnology Recent Development
12 Model Organism Market Dynamics
12.1 Model Organism Industry Trends
12.2 Model Organism Market Drivers
12.3 Model Organism Market Challenges
12.4 Model Organism Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global Model Organism Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2023 VS 2033
Table 2. Key Players of Prokaryote
Table 3. Key Players of Eukaryote
Table 4. Global Model Organism Market Size Growth Rate by Application (US$ Million), 2018 VS 2023 VS 2033
Table 5. Global Model Organism Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2023 VS 2033
Table 6. Global Model Organism Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Model Organism Revenue Forecast by Region (2024-2033) & (US$ Million)
Table 8. Global Model Organism Market Size of Top 10 Countries, 2018 VS 2023 VS 2033, (US$ Million)
Table 9. Global Model Organism Revenue by Players (2018-2023) & (US$ Million)
Table 10. Global Model Organism Market Share by Players (2018-2023)
Table 11. Global Top Model Organism Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Model Organism as of 2023)
Table 12. Ranking of Global Top Model Organism Companies by Revenue (US$ Million) in 2023
Table 13. Global 5 Largest Players Market Share by Model Organism Revenue (CR5 and HHI) & (2018-2023)
Table 14. Global Key Players of Model Organism, Headquarters and Area Served
Table 15. Global Key Players of Model Organism, Product and Application
Table 16. Global Key Players of Model Organism, Date of Enter into This Industry
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Global Model Organism Market Size by Type (2018-2023) & (US$ Million)
Table 19. Global Model Organism Revenue Market Share by Type (2018-2023)
Table 20. Global Model Organism Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 21. Global Model Organism Revenue Market Share by Type (2024-2033)
Table 22. Global Model Organism Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Model Organism Revenue Market Share by Application (2018-2023)
Table 24. Global Model Organism Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Model Organism Revenue Market Share by Application (2024-2033)
Table 26. North America Model Organism Revenue by Company (2021-2023) & (US$ Million)
Table 27. North America Model Organism Revenue by Type (2018-2023) & (US$ Million)
Table 28. North America Model Organism Revenue by Type (2024-2033) & (US$ Million)
Table 29. North America Model Organism Revenue by Application (2018-2023) & (US$ Million)
Table 30. North America Model Organism Revenue by Application (2024-2033) & (US$ Million)
Table 31. North America Model Organism Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 32. North America Model Organism Revenue by Country (2018-2023) & (US$ Million)
Table 33. North America Model Organism Revenue by Country (2024-2033) & (US$ Million)
Table 34. Europe Model Organism Revenue by Company (2021-2023) & (US$ Million)
Table 35. Europe Model Organism Revenue by Type (2018-2023) & (US$ Million)
Table 36. Europe Model Organism Revenue by Type (2024-2033) & (US$ Million)
Table 37. Europe Model Organism Revenue by Application (2018-2023) & (US$ Million)
Table 38. Europe Model Organism Revenue by Application (2024-2033) & (US$ Million)
Table 39. Europe Model Organism Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 40. Europe Model Organism Revenue by Country (2018-2023) & (US$ Million)
Table 41. Europe Model Organism Revenue by Country (2024-2033) & (US$ Million)
Table 42. Asia Pacific Model Organism Revenue by Company (2021-2023) & (US$ Million)
Table 43. Asia Pacific Model Organism Revenue by Type (2018-2023) & (US$ Million)
Table 44. Asia Pacific Model Organism Revenue by Type (2024-2033) & (US$ Million)
Table 45. Asia Pacific Model Organism Revenue by Application (2018-2023) & (US$ Million)
Table 46. Asia Pacific Model Organism Revenue by Application (2024-2033) & (US$ Million)
Table 47. Asia-Pacific Model Organism Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 48. Asia Pacific Model Organism Revenue by Region (2018-2023) & (US$ Million)
Table 49. Asia Pacific Model Organism Revenue by Region (2024-2033) & (US$ Million)
Table 50. Latin America Model Organism Revenue by Company (2021-2023) & (US$ Million)
Table 51. Latin America Model Organism Revenue by Type (2018-2023) & (US$ Million)
Table 52. Latin America Model Organism Revenue by Type (2024-2033) & (US$ Million)
Table 53. Latin America Model Organism Revenue by Application (2018-2023) & (US$ Million)
Table 54. Latin America Model Organism Revenue by Application (2024-2033) & (US$ Million)
Table 55. Latin America Model Organism Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 56. Latin America Model Organism Revenue by Country (2018-2023) & (US$ Million)
Table 57. Latin America Model Organism Revenue by Country (2024-2033) & (US$ Million)
Table 58. Middle East and Africa Model Organism Revenue by Company (2021-2023) & (US$ Million)
Table 59. Middle East and Africa Model Organism Revenue by Type (2018-2023) & (US$ Million)
Table 60. Middle East and Africa Model Organism Revenue by Type (2024-2033) & (US$ Million)
Table 61. Middle East and Africa Model Organism Revenue by Application (2018-2023) & (US$ Million)
Table 62. Middle East and Africa Model Organism Revenue by Application (2024-2033) & (US$ Million)
Table 63. Middle East and Africa Model Organism Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 64. Middle East and Africa Model Organism Revenue by Country (2018-2023) & (US$ Million)
Table 65. Middle East and Africa Model Organism Revenue by Country (2024-2033) & (US$ Million)
Table 66. Shanghai Model Organisms Center, Inc. Company Details
Table 67. Shanghai Model Organisms Center, Inc. Business Overview
Table 68. Shanghai Model Organisms Center, Inc. Model Organism Product and Services
Table 69. Shanghai Model Organisms Center, Inc. Model Organism Revenue in Model Organism Business (2018-2023) & (US$ Million)
Table 70. Shanghai Model Organisms Center, Inc. Model Organism SWOT Analysis
Table 71. Shanghai Model Organisms Center, Inc. Recent Development
Table 72. Gem Pharmatech Co., Ltd. Company Details
Table 73. Gem Pharmatech Co., Ltd. Business Overview
Table 74. Gem Pharmatech Co., Ltd. Model Organism Product and Services
Table 75. Gem Pharmatech Co., Ltd. Model Organism Revenue in Model Organism Business (2018-2023) & (US$ Million)
Table 76. Gem Pharmatech Co., Ltd. Model Organism SWOT Analysis
Table 77. Gem Pharmatech Co., Ltd. Recent Development
Table 78. Charles River Laboratories Company Details
Table 79. Charles River Laboratories Business Overview
Table 80. Charles River Laboratories Model Organism Product and Services
Table 81. Charles River Laboratories Model Organism Revenue in Model Organism Business (2018-2023) & (US$ Million)
Table 82. Charles River Laboratories Model Organism SWOT Analysis
Table 83. Charles River Laboratories Recent Development
Table 84. Envigo Company Details
Table 85. Envigo Business Overview
Table 86. Envigo Model Organism Product and Services
Table 87. Envigo Model Organism Revenue in Model Organism Business (2018-2023) & (US$ Million)
Table 88. Envigo Model Organism SWOT Analysis
Table 89. Envigo Recent Development
Table 90. Taconic Biosciences Company Details
Table 91. Taconic Biosciences Business Overview
Table 92. Taconic Biosciences Model Organism Product and Services
Table 93. Taconic Biosciences Model Organism Revenue in Model Organism Business (2018-2023) & (US$ Million)
Table 94. Taconic Biosciences Model Organism SWOT Analysis
Table 95. Taconic Biosciences Recent Development
Table 96. Jackson Laboratory Company Details
Table 97. Jackson Laboratory Business Overview
Table 98. Jackson Laboratory Model Organism Product and Services
Table 99. Jackson Laboratory Model Organism Revenue in Model Organism Business (2018-2023) & (US$ Million)
Table 100. Jackson Laboratory Model Organism SWOT Analysis
Table 101. Jackson Laboratory Recent Development
Table 102. Shanghai SLAC Company Details
Table 103. Shanghai SLAC Business Overview
Table 104. Shanghai SLAC Model Organism Product and Services
Table 105. Shanghai SLAC Model Organism Revenue in Model Organism Business (2018-2023) & (US$ Million)
Table 106. Shanghai SLAC Model Organism SWOT Analysis
Table 107. Shanghai SLAC Recent Development
Table 108. Joinn Laboratories Company Details
Table 109. Joinn Laboratories Business Overview
Table 110. Joinn Laboratories Model Organism Product and Services
Table 111. Joinn Laboratories Model Organism Revenue in Model Organism Business (2018-2023) & (US$ Million)
Table 112. Joinn Laboratories Model Organism SWOT Analysis
Table 113. Joinn Laboratories Recent Development
Table 114. Crown Biosciences Company Details
Table 115. Crown Biosciences Business Overview
Table 116. Crown Biosciences Model Organism Product and Services
Table 117. Crown Biosciences Model Organism Revenue in Model Organism Business (2018-2023) & (US$ Million)
Table 118. Crown Biosciences Model Organism SWOT Analysis
Table 119. Crown Biosciences Recent Development
Table 120. Pharmalegacy Company Details
Table 121. Pharmalegacy Business Overview
Table 122. Pharmalegacy Model Organism Product and Services
Table 123. Pharmalegacy Model Organism Revenue in Model Organism Business (2018-2023) & (US$ Million)
Table 124. Pharmalegacy Model Organism SWOT Analysis
Table 125. Pharmalegacy Recent Development
Table 126. Syngene International Company Details
Table 127. Syngene International Business Overview
Table 128. Syngene International Model Organism Product and Services
Table 129. Syngene International Model Organism Revenue in Model Organism Business (2018-2023) & (US$ Million)
Table 130. Syngene International Recent Development
Table 131. Janvier Labs Company Details
Table 132. Janvier Labs Business Overview
Table 133. Janvier Labs Model Organism Product and Services
Table 134. Janvier Labs Model Organism Revenue in Model Organism Business (2018-2023) & (US$ Million)
Table 135. Janvier Labs Recent Development
Table 136. GenOway Company Details
Table 137. GenOway Business Overview
Table 138. GenOway Model Organism Product and Services
Table 139. GenOway Model Organism Revenue in Model Organism Business (2018-2023) & (US$ Million)
Table 140. GenOway Recent Development
Table 141. Psychogenics Company Details
Table 142. Psychogenics Business Overview
Table 143. Psychogenics Model Organism Product and Services
Table 144. Psychogenics Model Organism Revenue in Model Organism Business (2018-2023) & (US$ Million)
Table 145. Psychogenics Recent Development
Table 146. Horizon Discovery Group Company Details
Table 147. Horizon Discovery Group Business Overview
Table 148. Horizon Discovery Group Model Organism Product and Services
Table 149. Horizon Discovery Group Model Organism Revenue in Model Organism Business (2018-2023) & (US$ Million)
Table 150. Horizon Discovery Group Recent Development
Table 151. Vitalstar Biotechnology Company Details
Table 152. Vitalstar Biotechnology Business Overview
Table 153. Vitalstar Biotechnology Model Organism Product and Services
Table 154. Vitalstar Biotechnology Model Organism Revenue in Model Organism Business (2018-2023) & (US$ Million)
Table 155. Vitalstar Biotechnology Recent Development
Table 156. Model Organism Market Trends
Table 157. Model Organism Market Drivers
Table 158. Model Organism Market Challenges
Table 159. Model Organism Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Model Organism Product Picture
Figure 2. Global Model Organism Market Size by Type (US$ Million): 2018 VS 2023 VS 2033
Figure 3. Global Model Organism Market Share by Type: 2023 VS 2033
Figure 4. Prokaryote Features
Figure 5. Eukaryote Features
Figure 6. Global Model Organism Market Size by Application (US$ Million): 2018 VS 2023 VS 2033
Figure 7. Global Model Organism Market Share by Application: 2023 VS 2033
Figure 8. Drug Discovery
Figure 9. Basic Research
Figure 10. Toxicity Test
Figure 11. Parasitological Study
Figure 12. Hereditary Disease Study
Figure 13. Others
Figure 14. Model Organism Report Years Considered
Figure 15. Global Model Organism Revenue, (US$ Million), 2018 VS 2023 VS 2033
Figure 16. Global Model Organism Market Size 2018-2033 (US$ Million)
Figure 17. Global Model Organism Market Size Market Share by Region: 2023 VS 2033
Figure 18. Global Model Organism Revenue Market Share by Region in 2018 VS 2023
Figure 19. Global Model Organism Revenue Market Share Forecast by Region (2024-2033)
Figure 20. Global Top 10 Model Organism Countries Ranking by Market Size (US$ Million) in 2023
Figure 21. Global Model Organism Market Size of Top 10 Countries, 2018 VS 2023 VS 2033, (US$ Million)
Figure 22. Global Model Organism Market Share by Players in 2023
Figure 23. Global Top Model Organism Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Model Organism as of 2023)
Figure 24. The Top 10 and 5 Players Market Share by Model Organism Revenue in 2023
Figure 25. North America Model Organism Revenue Market Share by Company in 2023
Figure 26. North America Model Organism Revenue Market Share by Type (2018-2033)
Figure 27. North America Model Organism Revenue Market Share by Application (2018-2033)
Figure 28. North America Model Organism Revenue Share by Country (2018-2033)
Figure 29. U.S. Model Organism Revenue (2018-2033) & (US$ Million)
Figure 30. Canada Model Organism Revenue (2018-2033) & (US$ Million)
Figure 31. Europe Model Organism Revenue Market Share by Company in 2023
Figure 32. Europe Model Organism Revenue Market Share by Type (2018-2033)
Figure 33. Europe Model Organism Revenue Market Share by Application (2018-2033)
Figure 34. Europe Model Organism Revenue Share by Country (2018-2033)
Figure 35. Germany Model Organism Revenue (2018-2033) & (US$ Million)
Figure 36. France Model Organism Revenue (2018-2033) & (US$ Million)
Figure 37. U.K. Model Organism Revenue (2018-2033) & (US$ Million)
Figure 38. Italy Model Organism Revenue (2018-2033) & (US$ Million)
Figure 39. Russia Model Organism Revenue (2018-2033) & (US$ Million)
Figure 40. Asia Pacific Model Organism Revenue Market Share by Company in 2023
Figure 41. Asia Pacific Model Organism Revenue Market Share by Type (2018-2033)
Figure 42. Asia Pacific Model Organism Revenue Market Share by Application (2018-2033)
Figure 43. Asia Pacific Model Organism Revenue Share by Region (2018-2033)
Figure 44. China Model Organism Revenue (2018-2033) & (US$ Million)
Figure 45. Japan Model Organism Revenue (2018-2033) & (US$ Million)
Figure 46. South Korea Model Organism Revenue (2018-2033) & (US$ Million)
Figure 47. India Model Organism Revenue (2018-2033) & (US$ Million)
Figure 48. Australia Model Organism Revenue (2018-2033) & (US$ Million)
Figure 49. Taiwan Model Organism Revenue (2018-2033) & (US$ Million)
Figure 50. Indonesia Model Organism Revenue (2018-2033) & (US$ Million)
Figure 51. Thailand Model Organism Revenue (2018-2033) & (US$ Million)
Figure 52. Malaysia Model Organism Revenue (2018-2033) & (US$ Million)
Figure 53. Philippines Model Organism Revenue (2018-2033) & (US$ Million)
Figure 54. Vietnam Model Organism Revenue (2018-2033) & (US$ Million)
Figure 55. Latin America Model Organism Revenue Market Share by Company in 2023
Figure 56. Latin America Model Organism Revenue Market Share by Type (2018-2033)
Figure 57. Latin America Model Organism Revenue Market Share by Application (2018-2033)
Figure 58. Latin America Model Organism Revenue Share by Country (2018-2033)
Figure 59. Mexico Model Organism Revenue (2018-2033) & (US$ Million)
Figure 60. Brazil Model Organism Revenue (2018-2033) & (US$ Million)
Figure 61. Argentina Model Organism Revenue (2018-2033) & (US$ Million)
Figure 62. Middle East and Africa Model Organism Revenue Market Share by Company in 2023
Figure 63. Middle East and Africa Model Organism Revenue Market Share by Type (2018-2033)
Figure 64. Middle East and Africa Model Organism Revenue Market Share by Application (2018-2033)
Figure 65. Middle East and Africa Model Organism Revenue Share by Country (2018-2033)
Figure 66. Turkey Model Organism Revenue (2018-2033) & (US$ Million)
Figure 67. Saudi Arabia Model Organism Revenue (2018-2033) & (US$ Million)
Figure 68. U.A.E Model Organism Revenue (2018-2033) & (US$ Million)
Figure 69. Shanghai Model Organisms Center, Inc. Revenue Growth Rate in Model Organism Business (2018-2023)
Figure 70. Gem Pharmatech Co., Ltd. Revenue Growth Rate in Model Organism Business (2018-2023)
Figure 71. Charles River Laboratories Revenue Growth Rate in Model Organism Business (2018-2023)
Figure 72. Envigo Revenue Growth Rate in Model Organism Business (2018-2023)
Figure 73. Taconic Biosciences Revenue Growth Rate in Model Organism Business (2018-2023)
Figure 74. Jackson Laboratory Revenue Growth Rate in Model Organism Business (2018-2023)
Figure 75. Shanghai SLAC Revenue Growth Rate in Model Organism Business (2018-2023)
Figure 76. Joinn Laboratories Revenue Growth Rate in Model Organism Business (2018-2023)
Figure 77. Crown Biosciences Revenue Growth Rate in Model Organism Business (2018-2023)
Figure 78. Pharmalegacy Revenue Growth Rate in Model Organism Business (2018-2023)
Figure 79. Syngene International Revenue Growth Rate in Model Organism Business (2018-2023)
Figure 80. Janvier Labs Revenue Growth Rate in Model Organism Business (2018-2023)
Figure 81. GenOway Revenue Growth Rate in Model Organism Business (2018-2023)
Figure 82. Psychogenics Revenue Growth Rate in Model Organism Business (2018-2023)
Figure 83. Horizon Discovery Group Revenue Growth Rate in Model Organism Business (2018-2023)
Figure 84. Vitalstar Biotechnology Revenue Growth Rate in Model Organism Business (2018-2023)
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries